Diagnostics and clinical trials provider Quest has posted its directors’ report and financial statements for the year ended 31 December 2005.A UK subsidiary of Quest Diagnostics Inc, the NYSE-listed business that says it carries out personal health testing on 145 million patients each year. Turnover for the year was £40m, well ahead of £37m (as…
Membership Required
You must be a HM Subscriber to view this content.
Already have an account? Sign In
©2025 All rights reserved LaingBuisson 
